GoodRx hit a 52-week high in pre-market trading, currently quoted at $3.90, up approximately 7%Market Movers·Nov 10, 2026 at 01:06 PMGDRX+1.42%
GoodRx delays third-quarter report as revenue restatement remains incompletePUBT·Nov 10, 2026 at 11:00 AMGDRX+1.42%
GoodRx Brings Prescription Pricing Intelligence to Google Cloud’s Gemini for Healthcare | GDRX Stock NewsStockTitan·Nov 10, 2026 at 05:05 AMGDRX+1.42%
GoodRx to Restate First-Half 2026 Financials Over Understated RevenuePUBT·Nov 2, 2026 at 09:34 PMGDRX+1.42%
GoodRx climbs 4% on launch of employer GLP-1 weight-loss serviceMarket Movers·Oct 29, 2026 at 03:21 PMGDRX+1.42%
GoodRx Launches Employer Direct Weight Loss Offering | GDRX Stock NewsStockTitan·Oct 29, 2026 at 05:15 AMGDRX+1.42%
GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Now Rated "Hold" by Sell-Side AnalystsMarket Beat·Oct 28, 2026 at 06:29 AMGDRX+1.42%
